Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations

4Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this case series, we describe four cases in which the use of gamma interferon release assays with purified protein derivative (PPD) as a stimulating antigen was able to demonstrate PPD-specific immune activation. This may help to improve the adequate diagnosis of (systemic) Mycobacterium bovis BCG infections after intravesical BCG instillations for bladder carcinoma. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Heemstra, K. A., Bossink, A. W. J., Spermon, R., Bouwman, J. J. M., Van Kieft, R. D., & Thijsen, S. F. T. (2012). Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations. Clinical and Vaccine Immunology, 19(6), 974–977. https://doi.org/10.1128/CVI.05597-11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free